PEG-Hemoglobin Conjugation via Optimized Reactant Ratios
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for preparing polyethylene glycol (PEG) conjugated hemoglobin (PEG-Hb) face challenges such as high costs, impurities, and a wide molecular weight range, which affect the yield and purity of the conjugate, as well as the oxygen affinity and circulation half-life of the resulting product.
Innovation Solution
The method involves mixing hemoglobin with 2-iminothiolane at a 7-8 molar excess concentration to form thiolated Hb, followed by adding PEG-maleimide at a 9-15 molar excess concentration to achieve a PEG-Hb conjugate with an average of 7.1-8.9 PEG molecules per Hb, using PEG with an average molecular weight of 4,000-6,000 Daltons, thereby optimizing the reactant ratios to enhance yield and purity.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Productivity
If traditional PEG conjugation methods are used with high reactant ratios, then conjugation efficiency is improved, but production cost increases and impurities increase
Solution Approach 1:
The patent optimizes the molar ratio parameters of reactants (hemoglobin to PEG-maleimide) to achieve optimal conjugation efficiency while minimizing impurities. By carefully controlling the reactant ratio, the method balances productivity with product purity, avoiding the need for excessive reactant ratios that generate more impurities.
Solution Approach 2:
The patent introduces 2-iminothiolane as an intermediary reagent that facilitates the conjugation reaction between hemoglobin and PEG-maleimide. This intermediary enables controlled thiolation of hemoglobin, creating reactive sites for PEG attachment while maintaining better control over the reaction and reducing unwanted side products.
2Productivity
If traditional PEG conjugation methods are used with high reactant ratios, then conjugation efficiency is improved, but production cost increases
Solution Approach 1:
The patent optimizes the molar ratio parameters of reactants to achieve the best balance between conjugation efficiency and production cost. By determining the optimal reactant ratio through systematic parameter optimization, the method reduces waste of expensive reagents while maintaining high productivity, thereby lowering overall production costs.
Solution Approach 2:
The patent applies controlled excess of reactants (within optimized limits) to drive the conjugation reaction to completion while avoiding the excessive reactant ratios that would increase costs. The method uses just enough excess reactant to achieve high conversion without generating excessive waste that would increase production costs.
3Duration of action of stationary object
If PEG conjugation is performed to increase circulation half-life, then hemoglobin stability is improved, but molecular weight distribution becomes wider
Solution Approach 1:
The patent performs preliminary thiolation of hemoglobin with 2-iminothiolane before the PEG conjugation step. This preliminary action creates uniform reactive sites on the hemoglobin molecules, ensuring that subsequent PEG attachment occurs at consistent locations and numbers, thereby narrowing the molecular weight distribution while still achieving the desired circulation half-life extension.
Solution Approach 2:
The patent optimizes reaction parameters including pH, temperature, and reactant ratios to control the degree and uniformity of PEG conjugation. By carefully controlling these parameters, the method achieves consistent PEG attachment across hemoglobin molecules, producing a more homogeneous product with narrower molecular weight distribution.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This approach results in a PEG-Hb conjugate with reduced oxygen affinity, improved molecular weight distribution, and increased efficiency, reducing impurities and production costs while maintaining effective oxygen delivery and circulation half-life.
Implementation Method 1
mixing hemoglobin with 2-iminothiolane in an aqueous diluent, wherein the 2-IT is at a concentration of between 7 and 8 molar excess in the diluent over the Hb concentration, to form thiolated Hb
Implementation Method 2
adding polyethylene glycol (PEG)-maleimide (Mal) to the thiolated Hb in the aqueous diluent, wherein the PEG-Mal is at a concentration of between 9 and 15 molar excess in the diluent over the Hb concentration to form a PEG-Hb conjugate
Data Source
Figure 1
AI summary
The present invention relates generally to methods for preparing polyethylene glycol ("PEG") conjugated hemoglobin ("Hb") using reduced reactant ratios. More specifically, the present invention relates to methods for preparing PEG conjugated Hb ("PEG-Hb") with enhanced yield and purity.